Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug
- PMID: 3019232
- PMCID: PMC176446
- DOI: 10.1128/AAC.30.1.110
Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug
Abstract
WIN 51711, a potent new antipicornavirus drug, has been shown to inhibit an early event in the replication cycle of human poliovirus type 2 and human rhinovirus type 2. WIN 51711 was not virucidal and had no measurable effect on the adsorption of [3H]uridine-labeled virions to cells. When virion penetration of the plasma membrane was determined through loss of sensitivity to neutralizing antisera, WIN 51711 had no effect on poliovirus penetration, but inhibited rhinovirus penetration by 40%. In the presence of WIN 51711, exposure of neutral red-encapsidated virus-infected cells to light at 3 h postinfection resulted in a 3-log reduction in the number of infectious centers, indicating that WIN 51711 maintained the viral RNA in the encapsidated state after penetrating the cell membrane. The inhibition of uncoating by WIN 51711 in the neutral red assay was found to be concentration dependent, with a concentration of 0.03 micrograms/ml resulting in a 90% inhibition of uncoating. Sucrose gradient sedimentation of lysates from whole cells infected with [3H]uridine-labeled poliovirus showed that poliovirions remained intact in the presence of WIN 51711, but were uncoated in the absence of drug. WIN 51711 also prevented thermal inactivation of poliovirus infectivity, indicating a direct stabilizing effect of this compound on virion capsid conformation.
Similar articles
-
Inhibition of poliovirus uncoating by disoxaril (WIN 51711).Virology. 1987 Sep;160(1):281-5. doi: 10.1016/0042-6822(87)90075-4. Virology. 1987. PMID: 2820136
-
In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug.Antimicrob Agents Chemother. 1985 Jun;27(6):883-6. doi: 10.1128/AAC.27.6.883. Antimicrob Agents Chemother. 1985. PMID: 2992365 Free PMC article.
-
In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug.Antimicrob Agents Chemother. 1989 Dec;33(12):2069-74. doi: 10.1128/AAC.33.12.2069. Antimicrob Agents Chemother. 1989. PMID: 2559655 Free PMC article.
-
The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating.Science. 1986 Sep 19;233(4770):1286-93. doi: 10.1126/science.3018924. Science. 1986. PMID: 3018924
-
Use of drug-resistance mutants to identify functional regions in picornavirus capsid proteins.Arch Virol Suppl. 1994;9:111-9. doi: 10.1007/978-3-7091-9326-6_12. Arch Virol Suppl. 1994. PMID: 8032243
Cited by
-
Oxysterol-binding protein family I is the target of minor enviroxime-like compounds.J Virol. 2013 Apr;87(8):4252-60. doi: 10.1128/JVI.03546-12. Epub 2013 Jan 30. J Virol. 2013. PMID: 23365445 Free PMC article.
-
In vitro activity of R 61837, a new antirhinovirus compound.Arch Virol. 1988;101(3-4):155-67. doi: 10.1007/BF01310997. Arch Virol. 1988. PMID: 2845889 Free PMC article.
-
An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures.J Virol. 2000 Apr;74(8):3929-31. doi: 10.1128/jvi.74.8.3929-3931.2000. J Virol. 2000. PMID: 10729171 Free PMC article.
-
A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation.Commun Biol. 2022 Nov 25;5(1):1293. doi: 10.1038/s42003-022-04252-5. Commun Biol. 2022. PMID: 36434067 Free PMC article.
-
Neutral red-labeled influenza virus loses photosensitivity during absorption to host cells but not to erythrocytes.Arch Virol. 1989;108(1-2):81-8. doi: 10.1007/BF01313745. Arch Virol. 1989. PMID: 2596976
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous